According to the latest report by IMARC Group, titled “Neurothrombectomy Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026,” the global neurothrombectomy devices market grew at a CAGR of around 6% during 2015-2020. Neurothrombectomy devices are medical instruments used to retrieve or destroy blood clots present in the cerebral arteries. These devices aid in the rapid achievement of recanalization, increasing efficacy in the treatment of large vessel occlusions and lowering the risk for hemorrhagic events. They also assist in reducing the mortality rate among patients and improving functional outcomes. Consequently, they find extensive application in the treatment of acute ischemic stroke (AIS) across the globe.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Global Neurothrombectomy Devices Market Trends:
Sedentary lifestyles and the rising instances of AIS, especially among the geriatric population, represent one of the key factors favorably impacting the growth of the market. Moreover, as per the World Health Organization (WHO), stroke is the leading cause of depression and dementia, which results in the sudden death of brain cells due to the lack of oxygen. As neurothrombectomy devices play a pivotal role in providing blood supply to the brain, the demand for these devices is escalating around the world. Apart from this, the leading manufacturers are introducing technologically advanced variants on account of the rapid approval process. For instance, Medtronic PLC launched its fourth-generation Solitaire X revascularization device in April 2019 for the treatment of AIS. This device has an optimized delivery system to improve efficacy and provide smooth navigation through complex anatomies. Furthermore, the growing popularity of minimally invasive (MI) surgeries is anticipated to impel the growth of the market. Looking forward, IMARC Group expects the market to grow at a CAGR of 5.70% during the forecast period (2021-2026).
- Based on the product, the market has been classified into clot retrievers, aspiration/suction devices, vascular snares, and other devices.
- On the basis of the end use, the market has been categorized into hospitals and clinics, ambulatory surgical centers, and others.
- Region-wise, the market has been segmented into North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (the United Kingdom, Germany, France, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa.
- The competitive landscape of the market has been examined, with some of the key players being Acandis GmbH, Shandong Weigao Group Medical Polymer Company Limited, Edwards Lifesciences Corporation, Johnson & Johnson Services, Inc., Koninklijke Philips N.V., Medtronic plc, Penumbra Inc., Phenox GmbH, Stryker Corporation, Teleflex Incorporated, Terumo Corporation, and Vesalio, LLC.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Follow us on twitter: @imarcglobal